Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma

SIMPLE SUMMARY: Neuroblastoma is a type of childhood cancer accounting for approximately 15% of childhood cancer deaths. Despite intensive treatment, including immunotherapy, prognosis of high-risk neuroblastoma is poor. Increasing amounts of research show that the fighting capacity of the immune sy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancers (Basel)
Prif Awduron: Szanto, Celina L., Cornel, Annelisa M., Tamminga, Sara M., Delemarre, Eveline M., de Koning, Coco C. H., van den Beemt, Denise A. M. H., Dunnebach, Ester, Tas, Michelle L., Dierselhuis, Miranda P., Tytgat, Lieve G. A. M., van Noesel, Max M., Kraal, Kathelijne C. J. M., Boelens, Jaap-Jan, Huitema, Alwin D. R., Nierkens, Stefan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8123570/
https://ncbi.nlm.nih.gov/pubmed/33926057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13092096
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg